BWAY
BrainsWay Ltd.
NASDAQ · Healthcare · Medical - Devices · IL
$14.22
−2.03%Year over year
Reported trailing growth
- Revenue
- +32.3%
- EBITDA
- +44.0%
- EBIT
- +307.6%
- EPS
- +185.4%
- Free cash flow
- -69.6%
- Operating cash flow
- -64.8%
Forward estimates
Based on analyst estimates
- Revenue
- +26.1%
- EBITDA
- +19.9%
- EPS
- -11.6%
Three-year CAGR
- Revenue
- +24.3%
- EBITDA
- +113.9%
- EBIT
- +210.8%
- Net income
- +161.3%
- EPS
- +365.1%
- Free cash flow
- +152.2%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026